Cipla Q3 profit up 7% to Rs 4 bn, India revenue swells 15% to Rs 16 bn

Cipla Ltd, India's fourth-largest drugmaker by revenue, said third-quarter net profit rose 7 percent on strong domestic sales, but fell short of analysts' estimates. Net profit attributable to shareholders climbed to Rs 4.01 billion ($62.54 million) in the quarter ended Dec. 31, from Rs 3.

75 billion a year earlier.  That compared with an average estimate of Rs 4.44 billion in profit drawn from 18 analysts polled by Thomson Reuters. Including a one-off positive impact of Rs 1.07 billion due to recalculation of deferred.

This article is no longer available in our repository.

There could be multiple reasons for this.